Consistently, high Cdc20 expression is associated with poor prognosis in oral squamous cell carcinoma [18], gastric cancer [23], urothelial bladder cancer [24], colorectal cancer [19], non-small cell lung cancer [25], and pancreatic cancer [26]. The gene discussed is CDC20; the disease is familial pancreatic carcinoma.